Consequences of the delayed diagnosis of Ataxia-Telangiectasia

Pediatrics

Volumn 102, Issue 1 I, 1998, Pages 98-100

  Cabana, Michael D ^a   Crawford, Thomas O ^a   Winkelstein, Jerry A ^a   Christensen, James R ^a,b   Lederman, Howard M ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS CHILDREN S CENTER   (United States)

Author keywords

fetoprotein; Ataxia; Ataxia telangiectasia; Diagnosis

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; ATAXIA; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; CEREBRAL PALSY; CHILD; DEGENERATIVE DISEASE; GAIT DISORDER; GENETIC COUNSELING; HUMAN; INFANT; KARYOTYPING; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; TELANGIECTASIA;

ADOLESCENT; ALPHA-FETOPROTEINS; ATAXIA TELANGIECTASIA; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DIAGNOSTIC ERRORS; FEMALE; GENES, RECESSIVE; GENETIC COUNSELING; HUMANS; INFANT; INFANT, NEWBORN; MALE; PATIENT CARE TEAM; RETROSPECTIVE STUDIES;

EID: 0031832573     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.102.1.98     Document Type: Article

References (11)

1. Gatti RA, Boder E, Vinter HV, Sparkes SS, Norman A, Lange K. Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine. 1991;70:99-117
2. Broder E. Ataxia-telangiectasia: an overview. In: Gatti RA, Swift M, eds. Ataxia-Telangiectasia, Genetics, Neuropathology, and Immunology of a Degenerative Disease of Childhood. New York, NY: Alan Liss, Inc; 1985:1-63
3. Woods CG, Taylor AMR. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. Q J Med. 1992;298:169-179
4. Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet. 1986;39:573-583
5. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268:1749-1753
6. Waldman TA, McIntire KR. Serum alpha-fetoprotein levels in patients with ataxia-telangiectasia. Lancet. 1972;2:112
7. Jason JM, Gelfand EW. Diagnostic considerations in ataxia-telangiectasia. Arch Dis Child. 1979;54:682-686
8. Wu JT, Roan Y, Knight JA. Serum AFP levels in normal infants: their clinical and physiological significance. In: Mizejewski GJ, Porter IH, eds. Alpha-Fetoprotein and Congenital Disorders. New York, NY: Academic Press, Inc; 1985:111-123
9. Taylor AMR, Harnden DG, Arlett CF, et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 1975;258: 427-429
10. Heppell A, Butterworth SV, Hollis RJ, Kennaugh AA, Beatty DW, Taylor AMR. Breakage of the T cell receptor α chain locus in non malignant clones from patients with ataxia telangiectasia. Hum Genet. 1988;79:360-364
11. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 1991;325:1831-1836